![]() |
Name |
Funalenone
|
Molecular Formula | C15H12O6 | |
IUPAC Name* |
4,6,7,9-tetrahydroxy-8-methoxy-3-methylphenalen-1-one
|
|
SMILES |
CC1=CC(=O)C2=C(C(=C(C3=C2C1=C(C=C3O)O)O)OC)O
|
|
InChI |
InChI=1S/C15H12O6/c1-5-3-6(16)10-12-9(5)7(17)4-8(18)11(12)14(20)15(21-2)13(10)19/h3-4,17-20H,1-2H3
|
|
InChIKey |
LHEJVMYQRYQFKB-UHFFFAOYSA-N
|
|
Synonyms |
Funalenone; 259728-61-5; 8-deoxyxanthoherquein; 1H-Phenalen-1-one, 3,4,7,9-tetrahydroxy-2-methoxy-6-methyl-; 4,6,7,9-tetrahydroxy-8-methoxy-3-methylphenalen-1-one; 3,4,7,9-tetrahydroxy-2-methoxy-6-methyl-1H-phenalen-1-one; CHEBI:65932; DTXSID00438324; J-016199; 3,4,7,9-tetrahydroxy-2-methoxy-6-methyl-phenalen-1-one; 1H-Phenalen-1-one,3,4,7,9-tetrahydroxy-2-methoxy-6-methyl-
|
|
CAS | 259728-61-5 | |
PubChem CID | 10334284 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 288.25 | ALogp: | 2.8 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 107.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.642 |
Caco-2 Permeability: | -5.282 | MDCK Permeability: | 0.00000393 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.245 | 20% Bioavailability (F20%): | 0.185 |
30% Bioavailability (F30%): | 0.991 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 92.75% |
Volume Distribution (VD): | 0.67 | Fu: | 18.04% |
CYP1A2-inhibitor: | 0.948 | CYP1A2-substrate: | 0.762 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.497 | CYP2C9-substrate: | 0.684 |
CYP2D6-inhibitor: | 0.078 | CYP2D6-substrate: | 0.204 |
CYP3A4-inhibitor: | 0.067 | CYP3A4-substrate: | 0.045 |
Clearance (CL): | 7.613 | Half-life (T1/2): | 0.787 |
hERG Blockers: | 0.045 | Human Hepatotoxicity (H-HT): | 0.029 |
Drug-inuced Liver Injury (DILI): | 0.954 | AMES Toxicity: | 0.489 |
Rat Oral Acute Toxicity: | 0.055 | Maximum Recommended Daily Dose: | 0.506 |
Skin Sensitization: | 0.942 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.412 | Eye Irritation: | 0.935 |
Respiratory Toxicity: | 0.254 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000966 | ![]() |
0.420 | D0K8KX | ![]() |
0.318 | ||
ENC000336 | ![]() |
0.420 | D06GCK | ![]() |
0.316 | ||
ENC004201 | ![]() |
0.418 | D07MGA | ![]() |
0.300 | ||
ENC004675 | ![]() |
0.414 | D04AIT | ![]() |
0.295 | ||
ENC002516 | ![]() |
0.413 | D0WY9N | ![]() |
0.274 | ||
ENC005647 | ![]() |
0.413 | D0G4KG | ![]() |
0.253 | ||
ENC003447 | ![]() |
0.413 | D0AZ8C | ![]() |
0.252 | ||
ENC004922 | ![]() |
0.402 | D0FX2Q | ![]() |
0.235 | ||
ENC002107 | ![]() |
0.402 | D07JHH | ![]() |
0.235 | ||
ENC000335 | ![]() |
0.400 | D01XWG | ![]() |
0.233 |